Literature DB >> 20464681

[Bovine fasciolosis in Switzerland: relevance and control].

G Knubben-Schweizer1, P Deplazes, P R Torgerson, C Rapsch, M L Meli, U Braun.   

Abstract

In Switzerland, bovine fasciolosis is an economically important but often overlooked disease of dairy cows. The intermediate host of Fasciola hepatica in Switzerland is Galba truncatula, an amphibious snail living in humid habitats which are infected by miracidia from recently hatched Fasciola eggs. The definitive hosts include cattle, sheep, goats, horses, and free-living ruminants. Infection of these hosts occur from metacercariae, usually encysted on vegetation. Infection risk depends on the location of the habitat on the farm. There is a lower risk for the intermediate host to become infected on pastures for young stock and dry cows than on pastures for dairy cows. This in turn results in a lower infection risk for young stock and dry cows than for dairy cows. When controlling the disease, epidemiologic factors such as treatment and pasture management strategies should be taken into account. If individual control measures are followed, infection pressure and prevalence in a herd can be significantly reduced. To support veterinarians and farmers in the control of fasciolosis, an interactive map showing potential risk areas for fasciolosis was created on the basis of geographical, meteorological, and biological data of the intermediate host and the free-living parasite stages.

Entities:  

Mesh:

Year:  2010        PMID: 20464681     DOI: 10.1024/0036-7281/a000053

Source DB:  PubMed          Journal:  Schweiz Arch Tierheilkd        ISSN: 0036-7281            Impact factor:   0.845


  3 in total

1.  [Multiple liver lesions accompanied by eosinophilia - a case report of fascioliosis].

Authors:  Eva Trifina; Johannes Spenger; Shahin Zandieh; Jörg Haller; Herbert Auer; Christian Osterreicher; Klaus Klaushofer; Peter Mikosch
Journal:  Wien Med Wochenschr       Date:  2011-09

2.  Enzyme-linked immunosorbent assays for the detection of equine antibodies specific to a recombinant Fasciola hepatica surface antigen in an endemic area.

Authors:  María Sol Arias; Pablo Piñeiro; George V Hillyer; Iván Francisco; Cristiana Filipa Cazapal-Monteiro; José Luis Suárez; Patrocinio Morrondo; Rita Sánchez-Andrade; Adolfo Paz-Silva
Journal:  Parasitol Res       Date:  2011-08-17       Impact factor: 2.289

3.  Fasciola hepatica in a country of low incidence: a tricky diagnosis.

Authors:  Stéphanie Perrodin; Laura Walti; Bruno Gottstein; Corina Kim-Fuchs; Daniel Candinas; Vanessa Banz
Journal:  Hepatobiliary Surg Nutr       Date:  2019-12       Impact factor: 7.293

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.